Skip to main content
. 2024 Apr 13;33(11):3871–3884. doi: 10.1007/s00787-024-02418-6

Table 1.

Sociodemographic and clinical characteristics of adolescents and parents with TS

TS group
Mothers (n = 75) Fathers (n = 63)
Adolescents’ gender, n (%)
Male 60 (80.0)
Female 15 (20.0)
Adolescents’ age, mean (SD) 14.8 (1.8)
Time since first symptoms (years), mean (SD) 8.1 (3.5)
Time since diagnosis of TS (years), mean (SD) 4.0 (3.0)
Treatment reported for tics, n (%) 54 (72.0)
Neuroleptics/Antipsychotics 51 (68.0)
Others 8 (10.7)
Other treatment reported, n (%) 19 (25.3)
Antidepressants 13 (17.3)
Anxiolytics 6 (8.0)
Attention-deficit/hyperactivity disorders 4 (5.3)
Sleep disorders 3 (4.0)
Actual symptoms reported by mothers, n (%)
ADHD 41 (54.7)
COD 16 (21.3)
Learning disabilities 34 (45.3)
Anxiety 51 (68.0)
Depression 16 (21.3)
Sleeping disorder 23 (30.7)
Medical monitoring for TS reported by mothers, n (%)
Psychiatrist or child psychiatrist 34 (45.3)
Psychologist 28 (37.3)
YGTSS scores, mean (SD)
Motor tics 13.2 (4.8)
Vocal tics 9.4 (6.1)
Overall impairment 11.3 (13.7)
Total 33.9 (20.0)
CY-BOCS scores, mean (SD)
Obsessions 2.4 (4.6)
Compulsions 3.6 (5.1)
Total 6.0 (9.0)
MOVES scores, mean (SD)
Motor tics 5.4 (2.8)
Vocal tics 2.9 (3.0)
Obsessions 2.1 (2.5)
Compulsions 3.0 (2.4)
Other associated symptoms 1.2 (2.0)
Total 14.2 (9.3)
CBCL scores reported by parents
Total problems, mean (SD) 53.6 (25.0) 44.1 (23.1)
Borderline or clinical range, n (%) 41 (57.7) 25 (41.7)
Internalizing symptoms, mean (SD) 17.6 (8.9) 14.8 (8.9)
Borderline or clinical range, n (%) 45 (61.6) 32 (52.5)
Externalizing symptoms, mean (SD) 14.3 (9.0) 11.0 (6.9)
Borderline or clinical range, n (%) 33 (44.0) 21 (33.3)
Parents’ age (years), mean (SD) 44.1 (4.7) 47.1 (6.2)
Parents’ marital status, n (%)
Single 1 (1.3) 1 (1.6)
Married/living with partner 64 (85.3) 58 (92.1)
Separated/divorced 9 (12.0) 4 (6.3)
Widowed 1 (1.3) 0
Parents’ level of education, n (%)
Lower than or equal to high school 44 (58.7) 37 (58.7)
Superior to high school 31 (41.3) 25 (40.3)
Family size, mean (SD) 4.0 (0.9) 3.9 (1.2)
Health problems, n (%) 23 (30.7) 20 (31.7)
Medical treatment, n (%) 29 (39.2) 19 (30.2)
Antidepressants 10 (13.3) 5 (7.9)
Anxiolytics 6 (8.0) 1 (1.6)
Hypnotics 2 (2.7) 0
Others 19 (25.3) 14 (22.2)
SF-36 scores, mean (SD)
Physical functioning 87.2 (16.6) 95.2 (6.2)
Role physical 78.1 (32.3) 82.4 (26.6)
Bodily pain 74.5 (25.3) 82.5 (17.4)
Vitality 46.2 (18.7) 61.1 (14.9)
Mental health 56.0 (19.7) 66.8 (19.1)
Role emotional 68.0 (40.7) 83.0 (30.1)
Social functioning 70.1 (24.6) 79.2 (22.2)
General health 65.7 (15.7) 70.1 (15.5)
WHOQOL-BREF scores, mean (SD)
Physical health 70.5 (18.0) 79.1 (12.7)
Psychological health 60.3 (17.8) 62.9 (14.9)
Social relationships 65.4 (18.7) 60.0 (24.6)
Environment 68.2 (16.0) 69.5 (15.9)
Anxiety
HADS-A score, mean (SD) 8.4 (4.1) 6.8 (3.7)
Possible or probable clinical case, n (%) 42 (56.0) 20 (31.7)
Depression
HADS-D score, mean (SD) 5.7 (3.7) 4.8 (4.2)
Possible or probable clinical case, n (%) 22 (29.3) 14 (22.2)